Daewon Pharmaceutical presents oral platform diabetes and obesity drug clinical data in the US
Predicted impact: Low
Early-stage US research presentation for an oral diabetes drug; no revenue impact yet.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.